Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • Fellowship Program, Pediatric Hematology/Oncology, 2006
    Children's National Medical Center
  • Residency Program, General Pediatrics, 2003
    Children's Hospital of Columbus
  • Internship Program, General Pediatrics, 2001
    Children's Hospital of Columbus
  • MD, 2000
    Ohio State University College of Medicine
  • BS, 1995
    The College of William & Mary

Board Certifications

  • American Board of Pediatrics/Hematology-Oncology

National Provider ID: 1194810325


Biography

Holly Jane Meany, M.D., is a pediatric oncologist at Children's National Health System. She is a member of the Solid Tumor Program. Dr. Meany's clinical research is focused on phase I clinical trials and pharmacology in the development of new agents for treating pediatric cancers.

In vitro cytotoxicity of ABT751 a novel tubulin inhibitor in pediatric solid tumor cell lines

(2006) Proceedings of the American Association for Cancer Research

Isolated del14q21 in a Case of Precursor Bcell Acute Lymphoblastic Leukemia

(2005) Cancer Genetics and Cytogenetics

Pediatric Phase I Trial Design Using a Pharmacodynamic Marker as the Primary Endpoint

(2008) Journal of Clinical Oncology

Pharmacokinetics of temozolomide administered in combination with O6benzylguanine in children and adolescents with refractory solid tumors

(2009) Cancer Chemotherapy Pharmacology

Phase 2 Trial of Recombinant Tumor Necrosis Factoralpha in Combination With Dactinomycin in Children With Recurrent Wilms Tumor

(2008) Journal of Immunotherapy

Utility of PET Scan to Predict Relapse in Pediatric Patients with Hodgkins Disease

(2007) Pediatric Blood & Cancer